The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 331:1449-1450 November 24, 1994 Number 21
NextNext

Prevention of Nephrotoxicity Induced by Radiocontrast Agents

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
The intravascular administration of iodinated contrast agents is part of many diagnostic and therapeutic radiologic procedures. Since these agents have no therapeutic value, it is important that they be safe. The contrast agents that have been in use for many years have a high osmolality and are ionic, and their administration has been associated with anaphylactoid events, cardiovascular instability, and nephrotoxicity. Recently, low-osmolality contrast agents, ionic and nonionic, have been introduced to reduce the incidence of side effects.

Nephrotoxicity caused by contrast agents is usually identified clinically by an increase in the serum creatinine concentration. In many studies, the condition . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.